Exercise during curative chemotherapy for breast cancer has proven benefits. It helps reduce fatigue, preserve muscle strength, improve fitness, and enhance overall quality of life. Staying physically active…
With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
NEW YORK (Reuters Health) – Accelerated radiation therapy is more effective than conventional fractionation for squamous cell carcinoma of the head and neck (HNSCC), but complications of treatment…
NEW YORK (Reuters Health) – Concomitant chemoradiation is better than sequential therapy for improving survival with locally advanced non-small-cell lung cancer (NSCLC), according to a patient-level meta-analysis reported…
NEW YORK (Reuters Health) – Women treated with chest radiation in childhood or adolescence are at increased risk for breast cancer at a young age, and their risk…
NEW YORK (Reuters Health) – Active surveillance for renal cortical neoplasm is a “reasonable treatment option” in older patients with comorbid illness, according to a single-center report from…
NEW YORK (Reuters Health) – Sunitinib and sorafenib significantly increase patients’ risk of arterial thromboembolic events, according to a report in the March 29th online issue of the…
NEW YORK (Reuters Health) – Adjuvant chemotherapy, with or without postoperative radiotherapy, improves survival in patients with operable non-small-cell lung cancer, according to a March 24th online report…
NEW YORK (Reuters Health) – Ultrasound surveillance is a safe alternative to immediate resection for small testicular masses discovered incidentally, Canadian researchers report. Small testicular masses are occasionally…
NEW YORK (Reuters Health) – Gene expression-based signatures for lung cancer don’t seem any better than currently used prognostic factors at identifying patients who need adjuvant chemotherapy, researchers…
NEW YORK (Reuters Health) – High-potency, stereotactic body radiation therapy (SBRT) may improve survival for patients with medically inoperable early stage lung cancer, results of a multicenter phase…
NEW YORK (Reuters Health) – As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to…
